Science

Scientists working on anti-Covid drugs using garlic essential oil

Sunderarajan Padmanabhan New Delhi | Updated on April 23, 2020 Published on April 23, 2020

Department of Biotechnology’s Centre of Innovative and Applied Bioprocessing (DBT-CIAB) at Mohali has planned a bouquet of research projects aimed at generating products that could be used for prevention, diagnosis or cure for the deadly Covid-19 infection that is currently sweeping over the entire world.

The plan has been designed to utilise the expertise of its scientists, who come from a diverse range of research backgrounds including chemistry, chemical engineering, biotechnology, molecular biology, nutrition, and nanotechnology.

Under the preventive platform, the Institute has planned to work on lignin-derived noble metal nanocomplexes for developing antiviral coating materials, and rose oxide-enriched citronella oil, carbopol and triethanolamine-formulated alcoholic sanitizer.

Under the therapeutics platform, the effort will be focussed on polypyrrollic photosensitizers and their nanoformulations for antiviral photodynamic therapy, microbial production of immunomodulatory and antiviral fructan biomolecules, and development and commercial manufacturing of nasal spray kit to ease chest congestion suffered in corona infection, etc.

Under the drug discovery platform, in turn, the research will explore the separation of therapeutic and valuable medicinal components from the peel and seeds of fruits and utilisation of natural garlic essential oil as an ACE 2 protein inhibitor for preventing SARS-CoV-2 invasion.

Besides, studies are to be conducted for the development of lignin-derived nanocarriers (LNCs) with potential for antiviral drug delivery and using curcumin-fortified whey protein powder as a nutraceutical.

The researchers would endeavour to come out with products that are biocompatible, low-cost and scalable and have set out with a timeline of six months to one year. The studies would be conducted in collaboration with chemical industries and other government laboratories with BSL-3 facility.

Twitter handle: @ndpsr

(India Science Wire)

 

Published on April 23, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.